Special article
Post-marketing studies of drug efficacy: Why?

https://doi.org/10.1016/0002-9343(85)90341-9Get rights and content

Abstract

In order to quantify the need for post-marketing studies of drug efficacy, the 100 drug uses (i.e., drug-indication pairs) that were most common In 1978 were reviewed. Of the 100 most common drug uses, 31 were not Food and Drug Administration (FDA)-approved at the time of initial marketing and 18 had not become FDA-approved, even subsequently. In 13, the use was based on the drug's secondary effect rather than on the primary effects Investigated before marketing. The efficacy of all was subject to modification by incompletely explored factors, including other drugs, patient age, other illnesses, pregnancy, etc. Specific examples are provided of important modifiers of the efficacy of these drugs that were not Investigated prior to marketing. Thus, despite the existence of sufficient data for the regulatory process to permit the marketing of these commonly used drugs, considerable gaps remain in the information needed for their optimal clinical use. Post-marketing studies of drug efficacy will be needed to fill these gaps.

References (33)

  • Ibuprofen (Motrin)-a new drug for arthritis

    Med Lett Drugs Ther

    (1974)
  • TW Wilson et al.

    Effect of dosage regimen on natriuretic response to furosemide

    Clin Pharmacol Ther

    (1975)
  • Clonidine (Catapres) for hypertension

    Med Lett Drugs Ther

    (1975)
  • S Shen et al.

    Clinical pharmacology of oral antidiabetic agents

    N Engl J Med

    (1977)
  • DC Webb-Johnson et al.

    Bronchodilator therapy

    N Engl J Med

    (1977)
  • Cited by (0)

    This work was supported by a grant from the Joint Commission on Prescription Drug Use, by National Institutes of Health Training Grant GM-07546, and by grants from the Charles A. Dana Foundation, the Rockefeller Foundation, and the Andrew W. Mellon Foundation.

    Current address: Department of Epidemiology, McGill University, 1020 Pine Avenue West, Montreal, Canada H3A 1A2.

    View full text